CN101249233B - Orally taken Chinese medicinal composition for curing hysteromyoma and ovary cyst and method of preparing the same - Google Patents
Orally taken Chinese medicinal composition for curing hysteromyoma and ovary cyst and method of preparing the same Download PDFInfo
- Publication number
- CN101249233B CN101249233B CN2008100233627A CN200810023362A CN101249233B CN 101249233 B CN101249233 B CN 101249233B CN 2008100233627 A CN2008100233627 A CN 2008100233627A CN 200810023362 A CN200810023362 A CN 200810023362A CN 101249233 B CN101249233 B CN 101249233B
- Authority
- CN
- China
- Prior art keywords
- percent
- hysteromyoma
- composite
- treatment
- cyst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010046798 Uterine leiomyoma Diseases 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title claims abstract description 5
- 239000000203 mixture Substances 0.000 title claims description 15
- 206010011732 Cyst Diseases 0.000 title abstract 3
- 208000031513 cyst Diseases 0.000 title abstract 3
- 210000001672 ovary Anatomy 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 9
- 241000218176 Corydalis Species 0.000 claims abstract description 6
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 3
- 208000025661 ovarian cyst Diseases 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 6
- 241000756943 Codonopsis Species 0.000 claims description 5
- 241000237903 Hirudo Species 0.000 claims description 5
- 241000195474 Sargassum Species 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 239000006187 pill Substances 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000002131 composite material Substances 0.000 abstract 4
- 239000003390 Chinese drug Substances 0.000 abstract 2
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003292 glue Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses an oral Chinese drug composite for curing hysteromyoma and oophoritic cyst and a preparation method thereof. The composite is composed of the following parts calculated according to the percentage by weight: 19.5 to 22.5 percent of root of herbaceous peony, 5.5 to 8.5 percent of red sage root, 8 percent of burred tuber, 4 to 6 percent of zedoary turmeric, 3.5 to 5.5 percent of corydalis tuber, 10 to 12 percent of prunella spike, 6.4 to 8.4 percent of Ligusticum chuanxiong hort, 7.6 to 9.6 percent of Chinese sage, 13 to 15 percent of asiabell, 4.5 percent of dried leech, 3.5 to 5.5 percent of kelp and 6 percent of licorice root; the composite adopts the preparing method that: firstly, the components are dried, ground and sifted for 200 meshes; then, the components are uniformly stirred and mixed according to the percentage by weight; at last the components are prepared into medicinal powder, or capsules or honeydewed pills according to the requirements, and are sterilized and packed. The oral Chinese drug composite has the advantages that the raw material sources are extensive, the cost is low, the oral administration is convenient, and the curative effect on the treatment of the hysteromyoma and the oophoritic cyst is remarkable.
Description
Technical field
The present invention relates to the Chinese medicine for oral administration composition and method of making the same, be specifically related to a kind of Chinese medicine for oral administration composition and method of making the same for the treatment of hysteromyoma, ovarian cyst.
Background technology
At present, the surgical operation therapies that adopt such as gynecological tumor such as hysteromyoma, ovarian cyst etc. more, the expenses of surgical treatment height, have a big risk, long-term effect is poor, patient's misery is many.
Summary of the invention
The object of the invention is: provide a kind of treat hysteromyoma,, the Chinese medicine for oral administration composition and method of making the same of ovarian cyst, draw materials extensively, with low cost, have no side effect, evident in efficacy to treatment hysteromyoma, ovarian cyst.
Technical solution of the present invention is: compositions is made up of following each component percentage by weight: Radix Paeoniae Alba 19.5-22.5%, Radix Salviae Miltiorrhizae 5.5-8.5%, rhizoma sparganic 8%, Rhizoma Curcumae 4-6%, Rhizoma Corydalis 3%, Spica Prunellae 10-12%, Rhizoma Chuanxiong 6.4-8.4%, Herba Salviae Chinensis 7.6-9.6%, Radix Codonopsis 13-15%, Hirudo 4.5%, Sargassum 3.5-5.5%, Radix Glycyrrhizae 6%.
The preparation method of said composition is: at first, select each component oven dry, pulverizing to cross 200 mesh sieves; Then, mix by weight percentage; At last, be made into powder or capsule or honeyed pill on request, sterilization packaging.
Using method: every day 3-4 time is oral, each 2-5g, 30 days one courses of treatment.
Raw material of the present invention is drawn materials extensively, and is with low cost, has no side effect, evident in efficacy to treatment hysteromyoma, ovarian cyst.
The specific embodiment
Below, by 3 embodiment, further specify concrete implementation process.Should be understood that these embodiment just in order to demonstrate the invention, but not limit the scope of the invention by any way.
Embodiment 1: at first select each component oven dry, pulverizing to cross 200 mesh sieves; Then, get Radix Paeoniae Alba 19.5g, Radix Salviae Miltiorrhizae 8.5g, rhizoma sparganic 8g, Rhizoma Curcumae 6g, Rhizoma Corydalis 3g, Spica Prunellae 10g, Rhizoma Chuanxiong 8.4g, Herba Salviae Chinensis 9.6g, Radix Codonopsis 13g, Hirudo 4.5g, Sargassum 3.5g and Radix Glycyrrhizae 6g mix 100g medicated powder; At last, with medicated powder glue capsule on request, sterilization packaging.
Embodiment 2: at first select each component oven dry, pulverizing to cross 200 mesh sieves; Then, get Radix Paeoniae Alba 21g, Radix Salviae Miltiorrhizae 7g, rhizoma sparganic 8g, Rhizoma Curcumae 5g, Rhizoma Corydalis 3g, Spica Prunellae 11g, Rhizoma Chuanxiong 7.4g, Herba Salviae Chinensis 8.6g, Radix Codonopsis 14g, Hirudo 4.5g, Sargassum 4.5g and Radix Glycyrrhizae 6g mix 100g medicated powder; At last, with medicated powder glue capsule on request, sterilization packaging.
Embodiment 3: at first select each component oven dry, pulverizing to cross 200 mesh sieves; Then, get Radix Paeoniae Alba 22.5g, Radix Salviae Miltiorrhizae 5.5g, rhizoma sparganic 8g, Rhizoma Curcumae 4g, Rhizoma Corydalis 3g, Spica Prunellae 12g, Rhizoma Chuanxiong 6.4g, Herba Salviae Chinensis 7.6g, Radix Codonopsis 15g, Hirudo 4.5g, Sargassum 5.5g and Radix Glycyrrhizae 6g mix 100g medicated powder; At last, with medicated powder glue capsule on request, sterilization packaging.
Case 1:
Hole XX, the woman, 34 years old, suffer from 2.3x2.1 centimetre of right ovary muscular tumor, often the outbreak, pain unbearably, through the dialectical treatment of this prescription two months, muscular tumor was contracted to 1.2x1.3 centimetre; Continue treatment four months, the complete obiteration of ovary muscular tumor.
Case 2:
Pan XX, the woman, 50 years old, suffer from the bilateral ovaries cyst, left and right sides is respectively the cyst of 1.8x1.6 centimetre and 2.4x1.2 centimetre, and through the dialectical treatment of this side two months, left and right sides cyst was contracted to 0.8x0.7 centimetre and 1.1x06 centimetre respectively; Continue treatment three months, the complete obiteration of cyst symptom.
Case 3
Feng XX, the woman, 37 years old, suffer from the cystic mass of about 12x6 centimetre of the cyclomastopathy in left side, through the dialectical treatment of this side one month, lump was contracted to 9x5 centimetre; Continue treatment three months, cystic mass is contracted to 3.2x4 centimetre; Control five months by this Fang Xu, the cystic mass complete obiteration.
Through clinical treatment observation, total effective rate reaches 86.5%.
Claims (2)
1. Chinese medicine for oral administration compositions for the treatment of hysteromyoma, ovarian cyst is characterized in that compositions is made up of following each component percentage by weight: Radix Paeoniae Alba 19.5-22.5%, Radix Salviae Miltiorrhizae 5.5-8.5%, rhizoma sparganic 8%, Rhizoma Curcumae 4-6%, Rhizoma Corydalis 3%, Spica Prunellae 10-12%, Rhizoma Chuanxiong 6.4-8.4%, Herba Salviae Chinensis 7.6-9.6%, Radix Codonopsis 13-15%, Hirudo 4.5%, Sargassum 3.5-5.5%, Radix Glycyrrhizae 6%.
2. a kind of Chinese medicine for oral administration preparation of compositions method for the treatment of hysteromyoma, ovarian cyst according to claim 1 is characterized in that: at first, select each component oven dry, pulverizing to cross 200 mesh sieves; Then, mix by weight percentage; At last, be made into powder, capsule on request, sterilization packaging.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100233627A CN101249233B (en) | 2008-04-03 | 2008-04-03 | Orally taken Chinese medicinal composition for curing hysteromyoma and ovary cyst and method of preparing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100233627A CN101249233B (en) | 2008-04-03 | 2008-04-03 | Orally taken Chinese medicinal composition for curing hysteromyoma and ovary cyst and method of preparing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101249233A CN101249233A (en) | 2008-08-27 |
| CN101249233B true CN101249233B (en) | 2010-11-17 |
Family
ID=39952943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100233627A Expired - Fee Related CN101249233B (en) | 2008-04-03 | 2008-04-03 | Orally taken Chinese medicinal composition for curing hysteromyoma and ovary cyst and method of preparing the same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101249233B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1416849A (en) * | 2001-11-05 | 2003-05-14 | 张高军 | Externally applied medicine for treating mastopathy and its prepn |
| CN1500501A (en) * | 2002-11-12 | 2004-06-02 | 王红波 | Compound traditional Chinese medicine formulation for curing hysteromyoma |
| CN101049479A (en) * | 2007-05-16 | 2007-10-10 | 北京艺信堂医药研究所 | Preparation of Chinese traditional medicine for treating barrenness caused by oviduct blocking |
-
2008
- 2008-04-03 CN CN2008100233627A patent/CN101249233B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1416849A (en) * | 2001-11-05 | 2003-05-14 | 张高军 | Externally applied medicine for treating mastopathy and its prepn |
| CN1500501A (en) * | 2002-11-12 | 2004-06-02 | 王红波 | Compound traditional Chinese medicine formulation for curing hysteromyoma |
| CN101049479A (en) * | 2007-05-16 | 2007-10-10 | 北京艺信堂医药研究所 | Preparation of Chinese traditional medicine for treating barrenness caused by oviduct blocking |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101249233A (en) | 2008-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100411669C (en) | Chinese medicine for treating chronic virus hepatitis B and its producing method | |
| CN101485806A (en) | Medicine for curing leukorrhea | |
| CN101249233B (en) | Orally taken Chinese medicinal composition for curing hysteromyoma and ovary cyst and method of preparing the same | |
| CN101455804A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN111467414A (en) | A Chinese medicinal composition for treating new coronavirus, and its preparation method | |
| CN101468184B (en) | Medicament for treating digestive system cancer and preparation method thereof | |
| CN101721584A (en) | Traditional Chinese medicine for treating gastropathy and gastric and duodenal ulcer | |
| CN104721372A (en) | Medicine for treating rheumatism, rheumatoid arthritis and arthralgia and preparation method of medicine | |
| CN103272055A (en) | Medicine for curing irregular menstruation and preparation method thereof | |
| CN102008579B (en) | Medicine for treating psoriasis and preparation method thereof | |
| CN106620105A (en) | Inflammation-diminishing spraying preparation | |
| CN1977904A (en) | Chinese medicine composition for treating gynecologic inflammation suchas pelvic inflammation, adnexal inflammation | |
| CN101897923A (en) | Chinese medicinal powder for treating nighttime lumbago | |
| CN101352496A (en) | Traditional Chinese medicine for treating hepatitis | |
| CN103908624A (en) | Traditional Chinese medicine composition for treating lymphatic cancer | |
| CN102100871A (en) | Chinese medicinal preparation for treating insomnia and amnesia | |
| CN103920132A (en) | Medicament for treating deficiency of yang of body and preparation method thereof | |
| CN103908626A (en) | Traditional Chinese medicine composition for treating leukemia | |
| CN104147583A (en) | Anti-inflammatory and anti-virus traditional Chinese medicine combination | |
| CN103860632A (en) | Drug for treating dermatophytoses and preparation method of drug | |
| CN104888159A (en) | Scapulohumeral periarthritis treating drug and preparation method thereof | |
| CN102847054A (en) | A Chinese medicinal formulation for treating liver cirrhosis | |
| CN101766714A (en) | Oral preparation for treating hernia | |
| CN101417091A (en) | Medicine for treating intractable chronic stomatocace | |
| CN106511837A (en) | Medicine for treating rheumatic arthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101117 Termination date: 20110403 |